THC AUTO 1:40 Feminised Seeds

$9.92$36.02

Please select pack size below

We send seeds in discreet stealth packaging worldwide.

We're Social - Spread the Love

THC AUTO 1:40 Feminised Cannabis Seeds by Medical Marijuana Genetics

THC AUTO 1:40 is an auto-flowering indica-dominant hybrid producing high levels of THC with good yields. Created by Medical Marijuana Genetics from the original Northern Lights variety crossed with a ruderalis to make it auto-flowering.

Long considered a useful and effective medical strain among patients. Northern Lights has been used for relief by suffer’s of chronic pain due to its high levels of THC (23%) and array of terpenes.  as a result, THC AUTO 1:40 Feminised users suffering from Headaches, Multiple Sclerosis, Nerve Damage, Pain, Sciatica, as well as cancer patients will find relief with this cannabis strain.

Suitable for both Indoor and Outdoor grows THC Auto 1:40 will grow well in majority of climates. Indoor cultivators can expect yields around 500g/m2 of grow space in approximately 70 days from seed. A suitable strain for making Rick Simpson Oil.

Characteristics

    • Genetics: No selection

      Original Northern Lights x Ruderalis

      Variety: No selection

      Mostly Indica

      Flowering Time: No selection

      Approx. 70 days from seed

      Flowering Type: No selection

      Autoflowering

      Sex: No selection

      Feminised

      THC Content: No selection

      23%

      CBD Content: No selection

      Low (0-1%)

      Yield: No selection

      High

      Grows: No selection

      Grows Indoors, Grows outdoors

      Medical Conditions: No selection

      , , , , ,

      Medical Properties: No selection

      Yes

      Effect: No selection

      , , ,

Genetics: No selection

Original Northern Lights x Ruderalis

Variety: No selection

Mostly Indica

Flowering Time: No selection

Approx. 70 days from seed

Flowering Type: No selection

Autoflowering

Sex: No selection

Feminised

THC Content: No selection

23%

CBD Content: No selection

Low (0-1%)

Yield: No selection

High

Grows: No selection

Grows Indoors, Grows outdoors

Medical Conditions: No selection

, , , , ,

Medical Properties: No selection

Yes

Effect: No selection

, , ,

Brand

Medical Marijuana Genetics

Medical Marijuana Genetics first learnt of the therapeutic properties of the cannabis plant in 2014. Whilst desperately treating the symptoms of one of the founders mother’s late stage pancreatic cancer. Not long after her first dose of cannabis oil, she was able to move around relatively pain free. This enabled her to tend to her beloved garden, in the weeks leading up to her death. Medical Marijuana Genetics teamed with award winning breeders from Spain, with the initial aim of creating a line of CBD dominant cannabis strains. Using genetics from a number of well established strains, Medical Marijuana Genetics successfully created Candida (CD-1). Aptly named after the founder’s mother and meaning ‘bright light’ in Latin. Medical Marijuana Genetics have had results ranging from 20.65% CBD with 0.7% THC to 10.65% CBD to 0.39% THC. These percentages represent the highest known consistent ratios in a CBD-rich seed strain ever created in Europe. Medical Marijuana Genetics created a further 12 elite strains using Candida as a parent. They have selected their favourite's of these to release alongside their flagship Candida strain. These have been selected to provide access (within lawful jurisdiction) to the widest range of therapeutics that the cannabis plant, and CBD in particular, has to offer. This includes treatments for symptoms such chronic pain, inflammation, seizures, convulsions, gastro-intestinal disorders, nausea, vomiting, skin conditions, bacterial infections, anxiety, depression, cancer cell growth and much more. All of the strains that are being launched are CBD dominant and have a CBD content of over 8%, but some strains veer towards a 1:1 ratio. In 2017 MMG strains won 5 Spannabis Champions Cups in Barcelona and Madrid. The awards include a 1st (BCN), 2nd and 3rd place (MAD)  in CBD categories for Orinoco OR1, Candida CD1 and Nightingale NN1 and a 2nd and 3rd in the Indica category for as yet unreleased genetics.
Medical marijuana Genetics Cannabis Seed breeders
Leave your review
Rating

Notify me when the item is back in stock.

THC AUTO 1:40 Feminised Cannabis Seeds | Medical Marijuana Genetics

THC AUTO 1:40 Feminised Seeds

9.2333.53

Please select pack size below

We send seeds in discreet stealth packaging worldwide.

We're Social - Spread the Love

THC AUTO 1:40 Feminised Cannabis Seeds by Medical Marijuana Genetics

THC AUTO 1:40 is an auto-flowering indica-dominant hybrid producing high levels of THC with good yields. Created by Medical Marijuana Genetics from the original Northern Lights variety crossed with a ruderalis to make it auto-flowering.

Long considered a useful and effective medical strain among patients. Northern Lights has been used for relief by suffer’s of chronic pain due to its high levels of THC (23%) and array of terpenes.  as a result, THC AUTO 1:40 Feminised users suffering from Headaches, Multiple Sclerosis, Nerve Damage, Pain, Sciatica, as well as cancer patients will find relief with this cannabis strain.

Suitable for both Indoor and Outdoor grows THC Auto 1:40 will grow well in majority of climates. Indoor cultivators can expect yields around 500g/m2 of grow space in approximately 70 days from seed. A suitable strain for making Rick Simpson Oil.

Characteristics

    • Genetics: No selection

      Original Northern Lights x Ruderalis

      Variety: No selection

      Mostly Indica

      Flowering Time: No selection

      Approx. 70 days from seed

      Flowering Type: No selection

      Autoflowering

      Sex: No selection

      Feminised

      THC Content: No selection

      23%

      CBD Content: No selection

      Low (0-1%)

      Yield: No selection

      High

      Grows: No selection

      Grows Indoors, Grows outdoors

      Medical Conditions: No selection

      , , , , ,

      Medical Properties: No selection

      Yes

      Effect: No selection

      , , ,

Genetics: No selection

Original Northern Lights x Ruderalis

Variety: No selection

Mostly Indica

Flowering Time: No selection

Approx. 70 days from seed

Flowering Type: No selection

Autoflowering

Sex: No selection

Feminised

THC Content: No selection

23%

CBD Content: No selection

Low (0-1%)

Yield: No selection

High

Grows: No selection

Grows Indoors, Grows outdoors

Medical Conditions: No selection

, , , , ,

Medical Properties: No selection

Yes

Effect: No selection

, , ,

Brand

Medical Marijuana Genetics

Medical Marijuana Genetics first learnt of the therapeutic properties of the cannabis plant in 2014. Whilst desperately treating the symptoms of one of the founders mother’s late stage pancreatic cancer. Not long after her first dose of cannabis oil, she was able to move around relatively pain free. This enabled her to tend to her beloved garden, in the weeks leading up to her death. Medical Marijuana Genetics teamed with award winning breeders from Spain, with the initial aim of creating a line of CBD dominant cannabis strains. Using genetics from a number of well established strains, Medical Marijuana Genetics successfully created Candida (CD-1). Aptly named after the founder’s mother and meaning ‘bright light’ in Latin. Medical Marijuana Genetics have had results ranging from 20.65% CBD with 0.7% THC to 10.65% CBD to 0.39% THC. These percentages represent the highest known consistent ratios in a CBD-rich seed strain ever created in Europe. Medical Marijuana Genetics created a further 12 elite strains using Candida as a parent. They have selected their favourite's of these to release alongside their flagship Candida strain. These have been selected to provide access (within lawful jurisdiction) to the widest range of therapeutics that the cannabis plant, and CBD in particular, has to offer. This includes treatments for symptoms such chronic pain, inflammation, seizures, convulsions, gastro-intestinal disorders, nausea, vomiting, skin conditions, bacterial infections, anxiety, depression, cancer cell growth and much more. All of the strains that are being launched are CBD dominant and have a CBD content of over 8%, but some strains veer towards a 1:1 ratio. In 2017 MMG strains won 5 Spannabis Champions Cups in Barcelona and Madrid. The awards include a 1st (BCN), 2nd and 3rd place (MAD)  in CBD categories for Orinoco OR1, Candida CD1 and Nightingale NN1 and a 2nd and 3rd in the Indica category for as yet unreleased genetics.
Medical marijuana Genetics Cannabis Seed breeders
Leave your review
Rating

Notify me when the item is back in stock.